Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||
| Net Income | -14,786 | -6,940 | -22,964 |
| Depreciation Amortization | 377 | 174 | 715 |
| Accounts payable and accrued liabilities | 503 | 196 | N/A |
| Other Working Capital | 1,479 | -295 | 804 |
| Other Operating Activity | 388 | 233 | 1,371 |
| Operating Cash Flow | $-12,039 | $-6,632 | $-20,074 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -4,589 | -783 | -1,908 |
| Investing Cash Flow | $-4,589 | $-783 | $-1,908 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -49 | -42 | N/A |
| Common Stock Issued | 17 | 17 | N/A |
| Other Financing Activity | 25,322 | 12,665 | 17,662 |
| Financing Cash Flow | $25,290 | $12,640 | $17,662 |
| Beginning Cash Position | 407 | 407 | 4,727 |
| End Cash Position | 9,069 | 5,632 | 407 |
| Net Cash Flow | $8,662 | $5,225 | $-4,320 |
| Free Cash Flow | |||
| Operating Cash Flow | -12,039 | -6,632 | -20,074 |
| Capital Expenditure | -4,589 | -783 | N/A |
| Free Cash Flow | -16,628 | -7,415 | -20,074 |